DSIP
No completed human trials extracted for DSIP. Animal-model evidence carries the indication cards below.
Research Evidence
Evidence shape
DSIP sits in the animal-only tier. The evidence map shows exactly one animal-only indication, preclinical or mechanistic research, and zero registered human trials; no study has been completed and no human data exists to judge quality or breadth. There are no human indications, no thin-study conditions, and no long-tail entries anywhere in the database, so the signal is the complete blankness of the clinical record beyond animal work.
Anecdotal efficacy
Side effects
Clinical research side effects
Clinical safety table not projected yet.
Anecdotal side effects
Price
price offers can be sorted by column
Dosing & Protocol
How DSIP is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.
No structured protocol details captured for this tier yet.
- Frequency
- daily
- Timing
- unspecified
- Route
- subQ
- Cycle
- unspecified
Clinician protocols dose 25 µg daily subQ (2 sources).
No structured protocol details captured for this tier yet.
Peptide Deep Dive
Peptide Deep Dive is not projected for this peptide yet.
Peptide feedback
0 forum repliesLive community discussion for DSIP, shown here in the site layout and continued on the TVR forum.
No peptide feedback yet
Start the peptide feedback thread on the TVR forum.